Dalvance (dalbavancin) Receives FDA Approval to Treat Acute Bacterial Skin and Skin Structure Infections in Pediatric Patients

NORTH CHICAGO, Ill., July 23, 2021 /PRNewswire/ — AbbVie (NYSE: ABBV) today announced that the U.S. Food and Drug Administration (FDA) approved Dalvance® (dalbavancin) for the treatment of acute bacterial skin and skin structure infections (ABSSSI) in pediatric patients from birth. Dalvance is the first single-dose option administered as a 30-minute intravenous (IV) infusion for… Read More »

Frontline worker hospitalized with COVID-19 has almost $1 million in medical bills

Loading the player… A woman who worked on the frontlines of medicine helping coronavirus patients has been hit with nearly $ 1 million in medical bills after recovering from a severe bout of COVID-19.  Shenita Russie, 42, a mobile respiratory therapist from Little Rock, Arkansas, caught the virus while working in Boston at the pandemic’s… Read More »

Health standards organizations help codify novel coronavirus info

As part of the global effort to manage and contain the coronavirus response, two global health standards organizations have introduced new content. Regenstrief Institute and SNOMED International, are supporting care teams globally to code and track SARS-CoV-2 testing and COVID-19 cases, and by extension support clinicians and researchers in their efforts to address its containment.… Read More »